2015
DOI: 10.1055/s-0035-1558981
|View full text |Cite
|
Sign up to set email alerts
|

Inherited Neuropathies

Abstract: Hereditary neuropathies (HNs) are among the most common inherited neurologic disorders and are diverse both clinically and genetically. Recent genetic advances have contributed to a rapid expansion of identifiable causes of HN and have broadened the phenotypic spectrum associated with many of the causative mutations. The underlying molecular pathways of disease have also been better delineated, leading to the promise for potential treatments. This chapter reviews the clinical and biological aspects of the comm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
29
0
1

Year Published

2016
2016
2022
2022

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(31 citation statements)
references
References 93 publications
(166 reference statements)
1
29
0
1
Order By: Relevance
“…Proteins which are involved in sensory neurodegeneration affect distinct molecular pathways: sphingolipid-metabolism, membrane-shaping of organelles, regulation of ion channels, endoplasmic reticulum turnover and axonal trafficking[1, 48]. However, the molecular mechanisms underlying sensory neurodegeneration are still incompletely understood and disease-causing mutations remain to be identified in a substantial number of patients.…”
Section: Introductionmentioning
confidence: 99%
“…Proteins which are involved in sensory neurodegeneration affect distinct molecular pathways: sphingolipid-metabolism, membrane-shaping of organelles, regulation of ion channels, endoplasmic reticulum turnover and axonal trafficking[1, 48]. However, the molecular mechanisms underlying sensory neurodegeneration are still incompletely understood and disease-causing mutations remain to be identified in a substantial number of patients.…”
Section: Introductionmentioning
confidence: 99%
“…Based on nerve conduction velocities, the disease can be divided into demyelinating CMT disease (CMT1), axonal CMT disease (CMT2) and intermediate CMT disease [2]. There is wide clinical heterogeneity among patients [3]. In general, patients with CMT disease experience slowly progressive weakness and wasting in the distal muscles, orthopedic abnormalities and sensory losses of temperature, touch and pain [1].…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, the concept of intermediate CMT with mMNCVs of 25 to 45 m/s appeared in the 1970s and has recently become more popular due to the importance of direct genetic diagnosis [5] .…”
Section: Introductionmentioning
confidence: 99%